Issue 22, 2023, Issue in Progress
From the journal:

RSC Advances

Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents

Cong-Min Peng,a   Shih-Wei Wang,bcd   Yi-Lin Hwang,a   Wen-Chun Sun,be   Li-Pin Chiu,fg   Yi-Ting Liu,a   Yu-Wei Lai*hi  and  Hsueh-Yun Lee*ajk  

* Corresponding authors

a School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
E-mail: hyl@tmu.edu.tw

b Institute of Biomedical Sciences, MacKay Medical College, New Taipei City, Taiwan

c Department of Medicine, MacKay Medical College, New Taipei City, Taiwan

d School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

e Division of Colon and Rectal Surgery, Department of Surgery, MacKay Memorial Hospital, Taipei, Taiwan

f Division of General Surgery, Taipei City Hospital Chushing Branch, Taipei, Taiwan

g General Education Center, University of Taipei, Taipei, Taiwan

h Division of Urology, Taipei City Hospital Renai Branch, Taipei, Taiwan
E-mail: dai77@tpech.gov.tw

i Department of Urology, School of Medicine and Shu-Tien Urological Science Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan

j PhD Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan

k TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan

Abstract

Correction for ‘CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents’ by Cong-Min Peng et al., RSC Adv., 2023, 13, 13169–13176, https://doi.org/10.1039/D3RA01927F.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D3RA90046K
Article type
Correction
Submitted
09 May 2023
Accepted
09 May 2023
First published
16 May 2023
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 14878-14878

Permissions

Request permissions

Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents

C. Peng, S. Wang, Y. Hwang, W. Sun, L. Chiu, Y. Liu, Y. Lai and H. Lee, RSC Adv., 2023, 13, 14878 DOI: 10.1039/D3RA90046K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements